TABLE 1.
Mechanism | miRNA | Target | Tissue | Model |
---|---|---|---|---|
Neuroinflammation | miR‐101 ↓ | NF‐κB ↑ | Serum and sural nerve | NP patients 39 |
miR‐124, −155 ↑ | SIRT1 ↓ | Serum | NP patients 40 | |
miR‐7a ↓ | NEFL/STAT3 ↑ | DRG | SNL rats 41 | |
miR‐590‐3p ↓ | RAP1A ↑ | DRG | Diabetic NP mice 42 | |
miR‐140 ↓ | S1PR1 ↑ | DRG | CCI rats 43 | |
miR‐144 ↓ | RASA1 ↑ | DRG | CCI mice 44 | |
miR‐130a‐3p ↓ | IGF‐1/IGF‐1R ↑ | Spinal cord | SCI rats 45 | |
miR‐378 ↓ | EZH2 ↑ | Spinal cord | CCI rats 46 | |
miR‐138 ↓ | TLR4/MIP‐1α/CCR1 ↑ | Spinal cord | pSNL rats 47 | |
miR‐15a/16 ↑ | GRK2 ↓ and p38 MAPK/NF‐κB ↑ | Spinal cord | CCI mice 48 | |
miR‐124 ↓ | GRK2 ↓ | Spinal cord microglia | SNI mice 49 | |
miR‐214‐3p ↓ | DNMT3a/CSF1/IL‐6 ↑ | Spinal cord astrocytes | SNL rats 50 | |
miR‐214 ↓ | Nav1.3/Bax ↑ | Spinal cord | SCI rats 51 | |
miR‐128 ↓ | p38 ↑ | Spinal cord | SCI rats 52 | |
miR‐128‐3p ↓ | ZEB1 ↑ | Spinal cord | CCI rats 53 | |
miR‐200b, −429 ↓ | ZEB1 ↑ | Spinal cord | CCI rats 54 | |
miR‐23a ↓ | CXCR4/TXNIP/NLRP3 ↑ | Spinal cord | pSNL mice 55 | |
miR‐155 ↓ | NOX2/ROS ↑ | Spinal cord microglia/macrophages | SCI mice 56 | |
TNFR1/p38‐MAPK/JNK/TRPA1 ↑ | Spinal cord dorsal horn | Chemotherapy induced NP rats 58 | ||
miR‐155 ↑ | SOCS1 ↓ and NF‐κB/p38 MAPK ↑ | Spinal cord | CCI rats 61 | |
Oxidative stress–TRPA1 pathway ↑ | Spinal cord | Chemotherapy induced NP rats 62 | ||
Autophagy | miR‐15a ↓ | AKT3 ↑ | Spinal cord microglia | CCI rats 63 |
miR‐145 ↓ | AKT3 ↑ | DRG | CCI rats 64 | |
miR‐20b‐5p ↓ | AKT3 ↑ | Dorsal spinal cord | CCI rats 65 | |
miR‐195 ↑ | ATG14 ↓ | Spinal cord microglia | SNL rats 66 | |
Ion channel expression | miR‐7a ↓ | β2 subunit of Scn2b ↑ | DRG | SNL and CCI rats 67 |
miR‐30b ↓ | Scn3a (encoding Nav1.3) ↑ | DRG and spinal cord | SNL rats 68 | |
miR‐96 ↓ | Scn3a (encoding Nav1.3) ↑ | DRG | CCI rats 69 | |
miR‐384‐5p ↓ | Scn3a (encoding Nav1.3) ↑ | DRG and spinal cord | CCI rats 70 | |
miR‐30b‐5p ↓ | Scn8a (encoding Nav1.6) ↑ | DRG | Chemotherapy induced NP rats 71 | |
miR‐182 ↓ | Scn9a (encoding Nav1.7) ↑ | DRG | SNI rats 72 | |
miR‐30b ↓ | Scn9a (encoding Nav1.7) ↑ | DRG | SNI rats 73 | |
miR‐17‐92 cluster ↑ |
Kv1.1, Kv1.4, Kv3.4, Kv4.3, Kv7.5, DPP10, Navβ1 ↓ |
DRG | SNL rats 74 | |
miR‐137 ↑ | Kcna2 (encoding Kv1.2) ↓ | DRG and spinal dorsal horn | CCI rats 75 | |
miR‐183‐5p ↓ | TREK‐1 ↑ | DRG | CCI rats 76 | |
miR‐183 cluster ↓ | Cacna2d1/Cacna2d2 ↑ | DRG | SNL mice 77 | |
miR‐103 ↓ | Cacna1c/Cacna2d1/Cacnb1 ↑ | Spinal dorsal horn | SNL rats 78 | |
miR‐141‐5p ↓ | TRPA1 ↑ | DRG | Chemotherapy induced NP rats 80 | |
miR‐449a ↓ | TRPA1/KCNMA1 ↑ | DRG | SNI mice 81 | |
Dysregulation of pain‐related mediators, protein kinases, and structural proteins | miR‐455‐3p ↑ | NGF and related genes ↓ | Serum | HIV/AIDS patients with symptomatic distal sensory polyneuropathy and NP 82 |
miR‐1 ↓ | BDNF ↑ | Sciatic nerve | CCI rats 83 | |
miR‐183 ↓ | BDNF ↑ | DRG | SNL rats 84 | |
miR‐206 ↓ | BDNF ↑ | DRG | CCI rats 85 | |
miR‐19a, −301, −132 ↓ | MeCP2/BDNF ↑ | DRG | SNI mice 86 | |
miR‐30c‐5p ↑ | TGF‐β ↓ | Serum, CSF, DRG, and spinal cord | SNI rats 16 | |
miR‐133a‐3p ↑ |
p‐p38 MAPK ↑ |
Sciatic nerve | DNP rats 87 | |
miR‐132 ↓ | MeCP2/p‐CREB ↑ | Spinal cord | SNI mice 88 | |
miR‐200b, −429 ↓ | DNMT3a ↑ | Nucleus accumbens neurons | SNL mice 89 | |
miR‐1 ↓ | Cx43 ↑ | Sciatic nerve | CCI rats 83 | |
miR‐15b ↑ | BACE1 ↓ | DRG | Chemotherapy induced NP rats 94 | |
Excitatory‐inhibitory imbalance | miR‐500 ↑ | GAD67 ↓ | Spinal cord dorsal horn | Chemotherapy induced NP or L5 VTR 95 |
miR‐23b ↓ | Nox4 ↑ and GAD65/67 ↓ | Spinal cord | SCI mice 96 | |
miR‐539 ↓ | NR2B ↑ | Contralateral ACC | CCI rats 97 | |
EV miRNA‐mediated neuron–glia communication | miR‐21 ↑ | Phagocyted by macrophages to promote a pro‐inflammatory phenotype | Serum exosomes | pSNL mice 98 |
miR‐21‐5p ↑ | Phagocyted by macrophages to promote a pro‐inflammatory phenotype | DRG exosomes | SNI mice 99 | |
miR‐23a ↑ | Phagocyted by macrophages to target A20 and enhance MI polarization | DRG EVs | SNI mice 102 |
Abbreviations: ACC, anterior cingulate cortex; BACE1, beta‐site amyloid precursor protein‐cleaving enzyme 1; BDNF, brain‐derived neurotrophic factor; CCI, chronic constriction injury; CCR1, C–C chemokine receptor 1; CSF, cerebro spinal fluid; CSF1, colony‐stimulating factor‐1; CXCR4, chemokine CXC receptor 4; DNMT3a, DNA methyltransferase 3a; DNP, diabetic neuropathic pain; DRG, dorsal root ganglion; EV, extracellular vesicle; EZH2, enhancer of zeste homolog 2; GRK2, G protein‐coupled receptor kinases 2; IGF‐1/IGF‐1R, insulin‐like growth factor‐1/insulin‐like growth factor‐1 receptor; KCNMA1, calcium‐activated potassium channel subunit α‐1; MeCP2, methyl cytosine–guanine dinucleotide (CpG)‐binding protein 2; MIP‐1a, macrophage inflammatory protein‐1 alpha; NEFL, neurofilament light polypeptide; NF‐κB, nuclear factor – kappa B; NGF, nerve growth factor; NLRP3, NOD‐like receptor protein 3; NOX2, NADPH oxidase 2; NP, neuropathic pain; pSNL, partial sciatic nerve ligation; RAP1A, Ras‐related protein 1A; RASA1, RAS P21 protein activator 1; ROS, reactive oxygen species; S1PR1, sphingosine‐1‐phosphate receptor 1; SCI, spinal cord injury; Scn2b, β2 subunit of the voltage‐gated sodium channel; SIRT1, histone deacetylase sirtuin 1; SNL, spinal nerve ligation; SOCS1, suppressor of cytokine signaling 1; STAT3, signal transducer and activator of transcription 3; TLR4, toll‐like receptor 4; TNFR1, TNF receptor 1; TRPA1, transient receptor potential ankyrin 1; TXNIP, thioredoxin‐interacting protein; VTR, ventral root transection; ZEB1, zinc finger E‐box binding homeobox 1.